Lintas, Estrella M.

HRN: 28-22-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2026
CEFUROXIME 750MG (VIAL)
04/05/2026
04/12/2026
IV
1.5 LD Then 750mg
LD Then Q8
Cholelithiasis
Remove - Pending Acceptance
04/05/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/05/2026
04/12/2026
IV
500mg
Every 8hours
Cholelithiasis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: